1-2 of 2
Stephen Sontag
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Randomized Phase II Trial of Polyphenon E versus Placebo in Patients at High Risk of Recurrent Colonic Neoplasia

Frank A. Sinicrope, Thomas R. Viggiano, Navtej S. Buttar, Louis M. Wong Kee Song, Kenneth W. Schroeder, Robert E. Kraichely, Mark V. Larson, Robert E. Sedlack, John B. Kisiel, Christopher J. Gostout, Abdul M. Kalaiger, Árpád V. Patai, Gary Della'Zanna, Asad Umar, Paul J. Limburg, Jeffrey P. Meyers, Nathan R. Foster, Chung S. Yang, Stephen Sontag
Journal: Cancer Prevention Research
Series: Author Choice
Cancer Prev Res (Phila) (2021) 14 (5): 573–580.
https://doi.org/10.1158/1940-6207.CAPR-20-0598
Published: 01 May 2021
View articletitled, Randomized Phase II Trial of Polyphenon E versus Placebo in Patients at High Risk of Recurrent Colonic Neoplasia
Open the PDF for Randomized Phase II Trial of Polyphenon E versus Placebo in Patients at High Risk of Recurrent Colonic Neoplasia in another window
Includes: Supplementary data
Journal Articles

Aberrant Crypt Foci in the Adenoma Prevention with Celecoxib Trial

Nancy L. Cho, Mark Redston, Ann G. Zauber, Adelaide M. Carothers, Jason Hornick, Andrew Wilton, Stephen Sontag, Norman Nishioka, Francis M. Giardiello, John R. Saltzman, Chris Gostout, Craig J. Eagle, Ernest T. Hawk, Monica M. Bertagnolli
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2008) 1 (1): 21–31.
https://doi.org/10.1158/1940-6207.CAPR-07-0011
Published: 09 June 2008
View articletitled, Aberrant Crypt Foci in the Adenoma Prevention with Celecoxib Trial
Open the PDF for Aberrant Crypt Foci in the Adenoma Prevention with Celecoxib Trial in another window
Includes: Supplementary data